Prof. Sammar fathy Elhabal | drug delivery | Best Researcher Award

Posted on by Academic achievements

Prof. Sammar fathy Elhabal | drug delivery | Best Researcher Award

Prof. Sammar fathy Elhabal, Modern University MTİ, Egypt

Sammar Fathy Ibrahim Elhabal, Ph.D., is a distinguished academic and researcher in the field of pharmaceutics, specializing in advanced drug delivery systems and nanotechnology. With a Ph.D. from Cairo University, Egypt, her expertise spans controlled release, ophthalmic and oral drug delivery, and nanofiber-based formulations. Dr. Elhabal has made significant contributions to various high-impact journals and is passionate about enhancing healthcare through innovative drug delivery technologies. She has held various academic positions and is committed to mentoring the next generation of pharmacists. 🌟💊📚

Professional Profile:

Scopus

Suitability for the Best Researcher Award

Dr. Sammar Fathy Ibrahim Elhabal is an exemplary candidate for the Best Researcher Award, with a well-rounded and impressive career in pharmaceutics, particularly in the field of advanced drug delivery systems and nanotechnology. Her academic qualifications, impactful research contributions, leadership in education, and dedication to advancing healthcare make her a standout scholar in her field.

Education & Experience

  • Ph.D. in Pharmaceutics, Faculty of Pharmacy, Cairo University, 2021 🎓
  • M.Sc. in Pharmaceutics, Faculty of Pharmacy, Tanta University, 2018 🎓
  • B.Sc. in Pharmaceutical Sciences (Honor), October 6 University, 2013 🎓
  • Lecturer, Pharmaceutics Department, Modern University for Technology & Information (MTI), Cairo, Egypt 📚
  • Area Manager, 19011 Pharmacies Chain, Giza, Egypt 🏥
  • Branch Manager, Roshdy Pharmacies Chain, Giza, Egypt 🏥

Professional Development

Dr. Sammar Fathy Elhabal has a strong background in teaching, research, and leadership within the pharmaceutical field. She has been an academic advisor and a member of various committees at the Modern University for Technology & Information (MTI). Dr. Elhabal has collaborated with faculty to develop new course material, facilitated professional development, and mentored students and junior faculty. Additionally, her commitment extends to research, particularly in drug delivery systems and nanotechnology. She is an active contributor to academic communities through her publications and research collaborations. 📚👩‍🏫💡

Research Focus

Dr. Elhabal’s research is focused on advanced drug delivery systems, with a special emphasis on nanotechnology. She explores areas such as nanofibers, ophthalmic and oral drug delivery, controlled release, and targeted drug delivery. Her work in nanotechnology, including nanofiber-based systems, aims to improve therapeutic outcomes through more efficient drug release and delivery methods. Dr. Elhabal is also investigating green, eco-friendly nanoparticles for use in medical formulations. Her work aims to make drug delivery more effective, sustainable, and patient-friendly. 💉🔬🌱

Awards & Honors

  • Best Publication Award, International Journal of Nanomedicine, 2024 🏆
  • Excellence in Research Award, Modern University for Technology & Information, 2023 🏅
  • Outstanding Lecturer Award, Faculty of Pharmacy, Tanta University, 2019 🌟
  • Research Excellence Award, Cairo University, 2018 🏅

Publication Top Notes:

  • 📄 Potential application of sucrose acetate isobutyrate, and glyceryl monooleate for nanonization and bioavailability enhancement of rivaroxaban tablets
  • 📄 Enhanced Antibacterial Activity of Clindamycin Using Molecularly Imprinted Polymer Nanoparticles Loaded with Polyurethane Nanofibrous Scaffolds for the Treatment of Acne Vulgaris
    • Cited by: 2
  • 📚 ANTI-OBESITY NUTRACEUTICALS: INSIGHTS INTO MECHANISMS OF ACTION AND POTENTIAL USE OF BIOCOMPATIBLE NANOCARRIERS FOR DELIVERY
    • Cited by: 1
  • 📄 Formulation, optimization and evaluation of ocular gel containing nebivolol Hcl-loaded ultradeformable spanlastics nanovesicles: In vitro and in vivo studies
    • Cited by: 10
  • 📄 FORMULATION AND STABILITY EVALUATION OF ANTI-OBESITY NUTRACEUITCAL BLEND OF WHITE KIDNEY BEAN EXTRACT (PHASEOLUS VULGARIS L.), PROPOLIS ETHANOLIC EXTRACT AND CRPIC3

 

 

Shymaa Hatem | Pharmaceutics and Pharmaceutical Technology | Women Researcher Award

Posted on by Academic achievements

Assist Prof. Dr.Shymaa Hatem | Pharmaceutics and Pharmaceutical Technology | Women Researcher Award

Assistant Professor at Future University in Egypt

Dr. Shymaa Hatem Abdel-Azeem is a distinguished academic and researcher in the field of pharmaceutics and pharmaceutical technology. She currently serves as a Lecturer at the Faculty of Pharmacy, Future University in Egypt. With over a decade of academic experience, she has contributed significantly to pharmaceutical research, focusing on advanced drug delivery systems and nanotechnology-based therapies for dermatological conditions. Dr. Shymaa is recognized for her leadership in various academic and professional organizations, contributing to the advancement of pharmaceutical sciences and women’s empowerment in the Arab world.

Profile:

Google Scholar

Education:

Dr. Shymaa earned her Ph.D. in Pharmaceutical Sciences (Pharmaceutical Technology) from Ain Shams University in June 2022. Her doctoral research focused on the “Preparation and Evaluation of Topical Nanoformulations for the Treatment of Melasma.” She holds an M.Sc. in Pharmaceutical Sciences (Pharmaceutics) from Ain Shams University, completed in 2018, where her thesis examined “Preparation and Characterization of Topical Antioxidant Formulations.” In 2010, she graduated with a B.Sc. in Pharmaceutical Sciences and Pharmaceutical Industries from Cairo University, achieving an overall grade of “Excellent.”

Experience:

Dr. Shymaa has been a key academic figure at Future University in Egypt since 2012. Starting as a Teaching Assistant in the Department of Pharmaceutics and Pharmaceutical Technology, she progressed to Assistant Lecturer and eventually to her current position as Lecturer. She is also a member of the Consulting Staff at several organizations, including the International Arab-African Council for Diplomatic Relations and Peace between Nations, and the Egyptian Association of Continuing Medical Education Development. In 2023, she was certified as an expert in Arabic women’s issues by the International Leadership Center.

Research Interest:

Dr. Shymaa’s research interests are centered around the development of innovative drug delivery systems, with a special focus on nanotechnology. Her work emphasizes the formulation of topical treatments for dermatological conditions such as melasma, psoriasis, and acne. She also explores the application of nanostructured lipid carriers and vesicular systems for the enhanced delivery of active pharmaceutical ingredients to the skin and brain. Her goal is to enhance the clinical efficacy of drugs using novel pharmaceutical technologies.

Awards:

Throughout her career, Dr. Shymaa has earned recognition for her contributions to the field of pharmaceutical sciences. In 2024, she completed the Training of Trainers (TOT) program from Ain Shams University, which certified her as a professional trainer. Her leadership and active participation in community services, particularly in women’s empowerment, have also been acknowledged by various professional organizations.

Publications:

Dr. Shymaa has published extensively in high-impact journals, with her research widely cited within the scientific community. Below are selected publications, complete with links and journal details:

“Clinical Cosmeceutical Repurposing of Melatonin in Androgenic Alopecia Using Nanostructured Lipid Carriers Prepared with Antioxidant Oils” (2018). Published in Expert Opinion on Drug Delivery and cited by 62 articles. Link to paper.

“Melatonin Vitamin C-based Nanovesicles for Treatment of Androgenic Alopecia: Design, Characterization, and Clinical Appraisal” (2018). Published in European Journal of Pharmaceutical Sciences and cited by 48 articles. Link to paper.

“Recent Advances in Antioxidant Cosmeceutical Topical Delivery” (2018). Published in Current Drug Delivery and cited by 36 articles. Link to paper.

“Background and Different Treatment Modalities for Melasma: Conventional and Nanotechnology-Based Approaches” (2020). Published in Journal of Drug Delivery Science and Technology and cited by 25 articles. Link to paper.

“Functionalized Chitosan Nanoparticles for Cutaneous Delivery of a Skin Whitening Agent: An Approach to Clinically Augment the Therapeutic Efficacy for Melasma Treatment” (2022). Published in Drug Delivery and cited by 14 articles. Link to paper.

“Optimization of the Colloidal Properties of Chitosan Nanoparticles Encapsulating Alpha-Arbutin” (2022). Published in Archives of Pharmaceutical Sciences Ain Shams University and cited by 8 articles. Link to paper.

“Novel Anti-Psoriatic Nanostructured Lipid Carriers for the Cutaneous Delivery of Luteolin: A Comprehensive In-Vitro and In-Vivo Evaluation” (2023). Published in European Journal of Pharmaceutical Sciences and cited by 5 articles. Link to paper.

Conclusion:

Shymaa Hatem Abdel-Azeem is a highly competent researcher with notable achievements in pharmaceutical nanotechnology and drug delivery systems. Her leadership roles and academic contributions, especially to women’s issues in the Arab world, underscore her qualifications for the “Research for Women Researcher Award.” By continuing to grow her international collaborations, expanding her research focus, and securing further funding, she can further solidify her standing as an influential figure in her field.